Arrowhead Pharmaceuticals Inc (ARWR) is near the top in its industry group according to InvestorsObserver. ARWR gets an overall rating of 70. That means it scores higher than 70 percent of stocks. Arrowhead Pharmaceuticals Inc gets a 83 rank in the Biotechnology industry. Biotechnology is number 18 out of 148 industries.
ARWR has an Overall Score of 70. Find out what this means to you and get the rest of the rankings on ARWR!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 70 means the stock is more attractive than 70 percent of stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Arrowhead Pharmaceuticals Inc Stock Today?
Arrowhead Pharmaceuticals Inc (ARWR) stock is trading at $31.72 as of 3:52 PM on Thursday, Sep 22, a decline of -$0.76, or -2.34% from the previous closing price of $32.48. The stock has traded between $31.21 and $32.45 so far today. Volume today is below average. So far 325,372 shares have traded compared to average volume of 753,740 shares.
Click Here to get the full Stock Report for Arrowhead Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
